Nvidia
@nvidia·2.2M subscribers·2.7K videos
BIO26 Healthcare Special Address
Posted
July 2, 2026
Views
3,119
Likes
169
Comments
13
Engagement
5.84%
July 2, 2026
3,119
169
13
5.84%
Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
1:02:47Now PlayingNVIDIA released a new toolkit called BioNeMo Agent Toolkit that's meant to let AI agents actually do hands-on scientific work in biology and chemistry - not just answer questions about it. Instead of an AI just chatting about a protein or a drug compound, it can now use real scientific software tools: predicting protein shapes, testing how well a drug molecule binds to a target, analyzing genetic sequencing data, and suggesting which lab experiments to try next.
Companies including Dassault Systèmes, Databricks, Eli Lilly, Schrödinger, Snowflake, and the University of Washington's Institute for Protein Design are adopting it, and both Anthropic and OpenAI are integrating it into their systems. The idea is that a general AI chatbot is bad at knowing which specialized scientific tool to use for a given task - this toolkit hands it the right tools and know-how so it can work more like a research assistant.
Chapters
Press Release
Subscribe to the NVIDIA AI Healthcare Newsletter
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.
